Projects per year
Organisation profile
Organisation profile
A cohort within the PMBRC, the Ocular Therapeutics Research Group (OTRG) is focused primarily on the development and production of novel therapeutics to treat various chronic and acute diseases of the eye. This is achieved by developing new nano- and micro-formulations, investigating novel therapeutics and designing innovative drug delivery platforms to improve patient outcomes and quality of life issues for a range of ophthalmic conditions. Using similarly developed formulations, these technologies are also applied to other pressing societal challenges that include Covid-19 and antimicrobial resistance.
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
-
SDG 2 Zero Hunger -
SDG 3 Good Health and Well-being -
SDG 4 Quality Education -
SDG 6 Clean Water and Sanitation -
SDG 8 Decent Work and Economic Growth -
SDG 9 Industry, Innovation, and Infrastructure -
SDG 12 Responsible Consumption and Production -
SDG 14 Life Below Water -
SDG 15 Life on Land -
SDG 16 Peace, Justice and Strong Institutions
Fingerprint
Dive into the research topics where Ocular Therapeutics Research Group is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Dr Sajid Asghar
- Department of Science - Post Doctoral Research Fellow
- Ocular Therapeutics Research Group
Person: Researcher
Projects
- 1 Active
-
Innovative Vision Research Postdoctoral Training Programme
Fitzhenry, L. (Principal Investigator) & Ames, T. (Project Lead)
01/01/2026 → 31/12/2030
Project: European
-
Breast cancer immunotherapy: mechanisms of immune evasion, biomarkers, and emerging therapeutic strategies
Shichkin, V. P., Morva, A., Ulaganathan, V. K., Erin, N., Nativi, C., Brezar, S. K. & Rani, S., 25 Apr 2026, In: Molecular cancer. 25, 1, 152.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Comorbid health conditions among adult individuals with dry eye disease: a systematic review of quantitative and qualitative studies: a systematic review of quantitative and qualitative studies
Golestaneh, D., Gooney, M., Ames, T., Stubbs, B., Sarfraz, M., Fitzhenry, L. & Matthews, E., 05 Aug 2026, In: Expert Review of Ophthalmology.Research output: Contribution to journal › Article
-
Designing biocompatible curcumin-loaded Pluronic F127 micelles for enhanced ocular drug delivery
Klahan, B., O'Reilly, N. J., Sigurdsson, H. H., Chauhan, A., Mering, S., Hakkarainen, J. J. & Fitzhenry, L., 05 Feb 2026, In: Journal of Drug Delivery Science and Technology. 119, 108100.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)
Prizes
-
-
Research and Development Achievement Award
Fitzhenry, L. (Recipient), O'Reilly, N. (Recipient) & Ames, T. (Recipient), 30 Oct 2024
Prize
File -
Activities
- 1 Oral presentation
-
Towards a Patient-Centred Approach: Building a Public and Patient Involvement Framework for Pre-Clinical Ocular Health Research
Ames, T. (Speaker)
11 Oct 2024Activity: Talk or presentation › Oral presentation
File
Press/Media
-
SETU’s OTRG wins prestigious Irish Pharma Industry award
Fitzhenry, L., O'Reilly, N. & Ames, T.
01/11/2024
1 item of Media coverage
Press/Media
-
November 29th: Maria Dickenson, Tess Ames, Dr Laurence Fitzhenry, and Georgiana Chiatis
29/11/2023
1 Media contribution
Press/Media
-
SETU Presents - The Dry Eye Information Evening South East Technological University (SETU) is delighted to announc
03/11/2023
1 item of Media coverage
Press/Media
Impacts
-
Pioneering PPIE in Ocular Therapeutics: A Case Study in Translational Engagement
Ames, T. (Participant) & Fitzhenry, L. (Participant)
Impact: Health and Well-being